MAPS
Live / Allowed — Notice of allowance issued (as of 30 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Apr 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98497938
- Mark type
- Stylized text
- Filed
- 12 Apr 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- CHRISTOPHER M. HANES
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; all of the foregoing excluding psychedelic medicines and therapies
Owner
- Affinivax, Inc., Cambridge, MA, US
- Affinivax, Inc., Cambridge, MA, US
Prosecution history
- 30 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Nov 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 12 Nov 2025 — OPPOSITION TERMINATED NO. 999999
- 12 Nov 2025 — OPPOSITION DISMISSED NO. 999999
- 26 Mar 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 23 Mar 2025 — OPPOSITION INSTITUTED NO. 999999
- 12 Dec 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED